May 23, 2016 12:30 pm
QALY stands for the quality of an adjusted life year. It is a ratio that economists use to determine the quality and quantity of life in order to ascertain the cost of medical interventions. But, as IMF Chairman Dr. Brian Durie asks, where do these...
May 16, 2016 3:30 pm
In this week’s video, Dr. Brian Durie describes how the iStopMM study aims to prevent myeloma in the entire adult population of adults who are age 40 or over in Iceland. BOTTOM LINE: While a seemingly lofty goal, iStopMM may bridge the pathway to...
May 13, 2016 11:00 am
The European Commission approved elotuzumab (Empliciti) for use in combination with lenalidomide (Revlimid) and dexamethasone for patients with multiple myeloma following progression on at least 1 prior therapy.
May 13, 2016 11:00 am
Dr. Rafat Abonour, Director, Multiple Myeloma Program at Indiana University Simon Cancer Center, and IMF Medical Liaison, speaks about myeloma drugs recently approved by the US Food and Drug Administration (FDA) and their real-world impact in the US...